Thanos Kosmidis received his MEng in Computing from Imperial College (UK), his MS in Information Networking from Carnegie Mellon University (USA), and is an Advanced Study Fellow at MIT’s Sloan School of Management (USA). He has more than 20 years of experience in the technology and commercial divisions of high-tech companies in the USA and Europe.
He cofounded CareAcross to support cancer patients throughout their journey. The company has grown to offer personalised services for patients internationally, based on scientific evidence and advanced, scalable algorithms. Direct benefits to patients (as also illustrated in proceedings in scientific conferences) include improved quality of life, physical activity, emotional wellbeing, weight management and more. Moreover, the platforms enhance clinicians’ workflows through remote patient monitoring and augmented consultation capabilities. The company partners with the industry to provide services such as patient support and engagement, real world evidence, clinical trial recruitment, and others.
Finally, Mr Kosmidis is supporting cancer services at an institutional level, internationally. More specifically, he has served as an Assembly Member for the European Commission’s “Mission on Cancer”. Moreover, he is a technology expert for the European Commission Initiative on Breast Cancer (ECIBC), and the Quality Assurance Scheme Development Group (QASDG) in particular.